Quinupristin/dalfopristin and linezolid: where, when, which and whether to use?

[21] Standing Medical Advisory Committee subgroup on antimicrobial resistance, 1998, PATH LEAST RES

[22] The oxazolidinone linezolid inhibits initiation of protein synthesis in bacteria [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1998, 42 (12) : 3251 - 3255

[23] TURNAK MR, 1998, 38 INT C ANT AG CHEM, P16

[24] Comparative in-vitro activity of SCH 27899, a novel everninomicin, and vancomycin [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1996, 37 (02) : 361 - 364

[25] Zurenko G E, 1997, Expert Opin Investig Drugs, V6, P151, DOI 10.1517/13543784.6.2.151

[26] 1999, DTSCH APOTHEKER ZEIT, V139, P4128

[21] Standing Medical Advisory Committee subgroup on antimicrobial resistance, 1998, PATH LEAST RES

[22] The oxazolidinone linezolid inhibits initiation of protein synthesis in bacteria [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1998, 42 (12) : 3251 - 3255

[23] TURNAK MR, 1998, 38 INT C ANT AG CHEM, P16

[24] Comparative in-vitro activity of SCH 27899, a novel everninomicin, and vancomycin [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1996, 37 (02) : 361 - 364

[25] Zurenko G E, 1997, Expert Opin Investig Drugs, V6, P151, DOI 10.1517/13543784.6.2.151

[26] 1999, DTSCH APOTHEKER ZEIT, V139, P4128